Ariessence pure PDGF+ is a potent, proprietary, topical, post-procedural enhancement, which utilizes recombinant technology to produce a pure, sterile, pharmaceutical-grade PDGF combined with hyaluronic acid. HA acts to retain or increase moisture, as a skin conditioning agent, and as a contributor to a healthy skin barrier.
Harnessing the only proven growth factor in aesthetics, ariessence is powered by PDGF, the same growth factor used in four separate FDA approved medical products with 28 yrs of therapeutic use. pure PDGF is now the next generation in skin rejuvenation.*
Zero blood draw. Sterile.
Pure confidence.
Without a blood draw, ariessence is easy to use, simple to understand, and can be applied quickly. pure PDGF+ is incredibly predictable and consistent, with a well-documented safety profile, resulting in enhanced outcomes. That’s as patient friendly as it gets.
Approved by the FDA for topical use and off-label for injections.
PROVEN
ariessence delivers faster results with superior potency due to the greatest concentration of growth factors in aesthetics. This simple, topical solution for post-procedural enhancement provides rapid results that your patients can see and feel.
FDA approval of these products was based on each product’s own formulation, controls, extensive safety and effectiveness data, including data derived from blinded, randomized, controlled human clinical trials (i.e., pivotal studies) which were conducted independently from ariessence pure PDGF+®.
PURE
Ariessence pure PDGF+ harnesses the power of nature’s most powerful growth factor for skin rejuvenation, PDGF-BB. The benefits of platelet-derived growth factor have been extensively studied by researchers. We utilize recombinant technology to produce a pure, sterile, pharmaceutical-grade product. And unlike products jammed with additives, Ariessence pure PDGF+ only contains four ingredients: water, sodium acetate, hyaluronic acid, and sh-polypeptide-59 dimer. There are no human cell components.
PDGF is a widely studied growth factor. A recent clinical trial demonstrates pure PDGF to be safe and effective for post-procedural application in aesthetics. rhPDGF-BB is used in 4 FDA-approved medical treatments (GEM 21S®, Augment®, Augment® Injectable, and Regranex®), and over 5.5 million patients have been treated with pure PDGF products in the last 28 years.*
POTENT
Pure PDGF+ contains up to 300,000 times the growth factor concentration of competitive applications. This incredible potency means results may be obtained with fewer applications, leaving you with happier clients.
ariessence pure PDGF+® is powered by the only proven growth factor available in aesthetics, driving rapid skin rejuvenation.
ariessence pure PDGF+ is a potent, cutting-edge, topical post-procedural enhancement that provides patients with naturally beautiful and healthier-looking skin. It offers a quick, easy-to-use, consistent, and trusted approach to post-procedure skin rejuvenation, We combine the benefits of one of the body’s most conserved proteins for skin rejuvenation, PDGF, with the soothing hydration of hyaluronic acid. When used following treatments including microneedling, RF microneedling, laser skin resurfacing, and peels, ariessence pure PDGF+ can enhance your patients’ results and reduce downtime.
providing an exceptional patient experience.
PREDICTABLE
Because ariessence pure PDGF+ is pharmaceutical grade, every application contains a consistent concentration. Unlike other products, pure PDGF+ does not rely on patient production of platelets. Because of this predictability, pure PDGF+ helps providers eliminate the guesswork in skin rejuvenation while giving patients a safe, consistent product, every time
Recombinant human rhPDGF–BB is a potent, sterile, consistent, off-the-shelf form of platelet-derived growth factor.
Made utilizing recombinant engineering to modify yeast, enabling the production of specific proteins or biological products by inserting a gene of interest into the yeast’s DNA
Purified to ensure consistency and sterility
Widely used in industries such as pharmaceutical, healthcare, and agriculture, allowing for the efficient and scalable creation of proteins.